微信关注
China
Total item
Cart Subtotal
￥ 0.00 “Akt Inhibitor”的搜索结果
-
KRas G12C inhibitor 3
Catalog No. A13018 Kras-G12C inhibitorKRas G12C inhibitor 3 is a compound that inhibits KRas G12C, extracted from patent US 20180072723 A1. 了解更多 -
KRas G12C inhibitor 2
Catalog No. A13064 Kras-G12C inhibitorKRas G12C inhibitor 2 is a compound that inhibits KRas G12C, extracted from patent US 20180072723 A1. 了解更多 -
KRas G12C inhibitor 1
Catalog No. A13152 Kras-G12C inhibitor 1KRas G12C inhibitor 1 is a compound that inhibits KRas G12C, extracted from patent US 20180072723 A1. 了解更多 -
JAK3 covalent inhibitor-1
Catalog No. A18926 JAK3 covalent 抑制剂JAK3 covalent inhibitor-1 is a potent and selective janus kinase 3 (JAK3) covalent inhibitor with an IC50 of 11 nM and shows 246-fold selectivity vs other JAKs. 了解更多 -
IKK-2 inhibitor VIII
Catalog No. A11452 -
MI-2 (Menin-MLL inhibitor 2)
Catalog No. A12929 Menin-MLL interaction 抑制剂MI-2 (Menin-MLL inhibitor 2)特异性结合menin并抑制menin与细胞中mll融合蛋白的相互作用。它能有效逆转mll融合蛋白通过下调mll融合蛋白致癌活性下游靶基因的表达来介导白血病转化。mi-2是更好地理解mll介导的白血病发生的新工具，代表了研究menin作为mll融合蛋白致癌辅助因子的作用的新方法。 了解更多 -
ROCK inhibitor
Catalog No. A15225 ROCK 抑制剂ROCK inhibitor是人类ROCK-1和ROCK-2同工酶的高效抑制剂，IC50值分别为0.6和1.1 nM。 了解更多 -
K-Ras(G12C) inhibitor 9
Catalog No. A14250 -
B-Raf-inhibitor 1
Catalog No. A14122 B-Raf 抑制剂B-Raf inhibitor 1是有效的选择性B-Raf抑制剂，对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。 了解更多 -
CFTR-Inhibitor-II
Catalog No. A13723 CFTR 抑制剂CFTR inhibitor II,也称为GlyH-101，是一种甘氨酸酰肼，可选择性和可逆地阻断CFTR通道（Ki = 4.3 uM）。 了解更多 -
Cysteine Protease inhibitor
Catalog No. A21048 cysteine protease inhibitorCysteine Protease inhibitor is an inhibitor of cysteine protease. 了解更多 -
PLpro inhibitor
Catalog No. A21044 Plpro inhibitorPLpro inhibitor is a potent inhibitor of papain-like protease (PLpro) with IC50 of 2.6 uM. 了解更多 -
Arginase inhibitor 1
Catalog No. A21007 arginases I and II inhibitorArginase inhibitor 1 is a potent inhibitor of human arginases I and II with IC50s of 223 and 509 nM, respectively. 了解更多 -
Btk inhibitor 1 R enantiomer hydrochloride
Catalog No. A21865 BTK inhibitorBtk inhibitor 1 R enantiomer hydrochloride (Ibrutinib analog hydrochloride) (Compound 14) is a covalent and irreversible Bruton??s tyrosine kinase (BTK) inhibitor and can be used in synthesis of Ibrutinib and ibrutinib-based activity-based probes (ABPs). 了解更多 -
Btk inhibitor 1 (R enantiomer)
Catalog No. A21861 BTK inhibitorBtk inhibitor 1 R enantiomer (Ibrutinib analog) (Compound 14) is a covalent and irreversible Bruton??s tyrosine kinase (BTK) inhibitor and can be used in synthesis of Ibrutinib and ibrutinib-based activity-based probes (ABPs). 了解更多 -
Thrombin Inhibitor 2
Catalog No. A21814 thrombin inhibitorThrombin Inhibitor 2 is a small molecule direct thrombin inhibitor, extracted from US8541580B2. Thrombin Inhibitor 2 has antithrombotic activity. 了解更多 -
GSK-3 inhibitor 1
Catalog No. A21803 -
Glyoxalase I inhibitor free base
Catalog No. A21721 Glyoxalase I (GLO1) inhibitorGlyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents. 了解更多 -
USP7/USP47 inhibitor
Catalog No. A21484 USP7/USP47 inhibitorUSP7/USP47 inhibitor is a selective ubiquitin-specific protease 7/47 (USP7/USP47) inhibitor, with EC50s of 0.42 μM and 1.0 μM, respectively. 了解更多 -
Mutant IDH1 inhibitor
Catalog No. A21150 mutant IDH1 R132H inhibitorMutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM. 了解更多 -
Mutant EGFR inhibitor
Catalog No. A21144 EGFR inhibitorMutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多 -
Nav1.7 inhibitor
Catalog No. A21141 -
HDACs/mTOR Inhibitor 1
Catalog No. A13462 HDACs/mTOR Inhibitor 1HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies. 了解更多 -
IRAK inhibitor 4
Catalog No. A11458 IRAK4 inhibitorIRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4(IRAK4) inhibitor. 了解更多 -
IRAK inhibitor 2
Catalog No. A11456 interleukin-1 receptor associated kinase inhibitorIRAK inhibitor 2 is interleukin-1 receptor associated kinase inhibitor . 了解更多 -
IRAK inhibitor 1
Catalog No. A11455 IRAK-4 inhibitorIRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM, is poorly active against JNK-1 and JNK-2 with IC50 of 3.801 μM, and >10 μM, respectively. 了解更多 -
Glycolic acid oxidase inhibitor 1
Catalog No. A13016 glycolate oxidase inhibitorGlycolic acid oxidase inhibitor 1 is a glycolate oxidase inhibitor, extracted from patent EP0021228A1, in Table IV. 了解更多 -
Cot inhibitor-1
Catalog No. A11366 -
CNT2 inhibitor-1
Catalog No. A12632 CNT2 InhibitorCNT2 inhibitor-1 is a potent concentrative nucleoside transporter 2 Inhibitor (CNT2), with an IC50 of 640 nM for hCNT2. 了解更多 -
mTOR inhibitor-2
Catalog No. A13035 mTOR inhibitormTOR inhibitor-2 is a highlt potent, selective and oral mTOR inhibitor with an IC50 of 7 nM. mTOR inhibitor-2 inhibits cellular phosphorylation of mTORC1 (pS6 and p4E-BP1) and mTORC2 (pAKT (S473)) substrates. 了解更多 -
MK-2 Inhibitor III
Catalog No. A13608 MAPKAP-K2 (MK-2) inhibitorMK-2 Inhibitor III (compound 16) is an orally active, selective, and ATP-competitive MAPKAP-K2 (MK-2) inhibitor with an IC50 of 0.85 nM. 了解更多 -
Glyoxalase I inhibitor
Catalog No. A11433 Glyoxalase I inhibitorGlyoxalase I inhibitor is a potent Glyoxalase I inhibitor, candidate for anticancer agents. 了解更多 -
Malic enzyme inhibitor ME1
Catalog No. A18564 ME1 inhibitorMalic enzyme inhibitor ME1 (ME1; compound 1) is a potent inhibitor of Malic enzyme (ME1) with an IC50 of 0.15 μM. 了解更多 -
MARK4 inhibitor 1
Catalog No. A18695 (MARK4 inhibitorMARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis. 了解更多 -
URAT1 inhibitor 1
Catalog No. A18720 URAT1 inhibitorURAT1 inhibitor 1 (1g) is a uric acid transporter 1 (URAT1) inhibitor, with an IC50 of 32 nM. URAT1 inhibitor 1 has potential to treat hyperuricemia associated with gout. 了解更多 -
p32 Inhibitor M36
Catalog No. A18846 p32 mitochondrial protein inhibitorp32 inhibitor M36 (M36) is a p32 mitochondrial protein inhibitor, which binds directly to p32 and inhibits p32 association with LyP-1. 了解更多 -
HSP27 inhibitor J2
Catalog No. A18874 HSP27 inhibitorHSP27 inhibitor J2 (J2) is a HSP27 inhibitor, which significantly induces abnormal HSP27 dimer formation and inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function thereof. 了解更多 -
ROCK inhibitor-2
Catalog No. A18912 ROCK1/ROCK2 inhibitorROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC50s of 17 nM and 2 nM, respectively. 了解更多 -
CD38 inhibitor 1
Catalog No. A19032 CD38 inhibitorCD38 inhibitor 1 (compound 78c) is a potent CD38 inhibitor with IC50s of 7.3 nM and 1.9 nM for hCD38 and mouse CD38. 了解更多 -
SEC inhibitor KL-2
Catalog No. A19043 SEC inhibitorSEC inhibitor KL-2 (KL-2), a peptidomimetic lead compound, is a potent, selective super elongation complex (SEC) inhibitor and disrupts the interaction between the SEC scaffolding protein AFF4 and P-TEFb, resulting in impaired release of Pol II from promoter-proximal pause sites and a reduced average rate of processive transcription elongation. 了解更多 -
BRM/BRG1 ATP Inhibitor-1
Catalog No. A19059 BRM/BRG1 ATP InhibitorBRM/BRG1 ATP Inhibitor-1 is an allosteric dual brahma homolog (BRM)/SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 2 (SMARCA2) and brahma related gene 1 (BRG1)/SMARCA4 ATPase activity inhibitor, both IC50s are below 0.005 ?M. 了解更多 -
DNA2 inhibitor C5
Catalog No. A19091 DNA2 inhibitorDNA2 inhibitor C5 is a potent, competitive and specific inhibitor of DNA2 nuclease activity with an IC50 of 20 μM. 了解更多 -
ML-9 hydrochloride
Catalog No. A17856 MLCK inhibitorML-9 is a selective and potent inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity. ML-9 inhibits inhibits MLCK, PKA and PKC activity with Ki values of 4, 32 and 54 μM, respectively. ML-9 induces autophagy by stimulating autophagosome formation and inhibiting their degradation. 了解更多 -
Rigosertib
Catalog No. A21868 multi-kinase inhibitorRigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 了解更多 -
Rigosertib sodium
Catalog No. A21824 multi-kinase inhibitorRigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 了解更多 -
Cenisertib
Catalog No. A11262 multi-kinase inhibitorCenisertib (AS-703569) is a multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. 了解更多 -
3-Hydroxyanthranilic acid
Catalog No. A22292 immunomodulatory agent3-Hydroxyanthranilic Acid (3-HAA, 3-HANA), a tryptophan metabolite, has an immunomodulatory effect that may result from inhibition of PI3K/Akt/mTOR and NF-κB activity, thereby decreasing the production of pro-inflammatory mediators. 了解更多 -
Loureirin A
Catalog No. A22313 flavonoidLoureirin A is a flavonoid extracted from Dragon's Blood, can inhibit Akt phosphorylation, and has antiplatelet activity. 了解更多
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
ADOOQ 产品质量保证
We promise all products to perform as described.